Table S3. Correlation between expression levels of 9 abnormally expressed lncRNAs and clinical characteristics of NPSLE patients.

Clinical characteristics	r vs. P	NONHSAT208182.1	NONHSAT001281.2	NONHSAT024353.2	NONHSAT182114.1	NONHSAT106801.2	NONHSAT039491.2	ENST00000356215	NONHSAT087499.2	NONHSAT207026.1
SLEDAI	r	–0.17	–0.09	–0.28	–0.07	–0.36	–0.44	0.09	0.09	0.30
	P	0.40	0.65	0.16	0.72	0.07	0.02	0.66	0.67	0.14
Age	r	–0.001	–0.22	–0.20	0.04	–0.03	0.15	–0.19	–0.11	–0.12
	P	0.99	0.27	0.32	0.86	0.89	0.47	0.35	0.58	0.56
Duration of disease	r	0.24	0.26	0.01	0.02	0.07	0.35	0.08	–0.07	–0.23
	P	0.23	0.20	0.98	0.91	0.73	0.08	0.69	0.73	0.26
Olfactory threshold	r	–0.25	–0.35	0.23	–0.33	–0.21	0.43	–0.64	–0.16	0.09
	P	0.49	0.32	0.52	0.35	0.57	0.22	0.05	0.66	0.81
Olfactory memory	r	0.13	–0.68	–0.27	0.07	–0.53	–0.75	–0.20	–0.23	0.04
	P	0.73	0.03	0.44	0.86	0.11	0.01	0.58	0.52	0.92
WBC (CSF)	r	–0.07	0.15	–0.56	–0.33	–0.16	0.26	–0.25	–0.36	0.17
	P	0.82	0.63	0.06	0.29	0.62	0.42	0.43	0.26	0.60
Protein (CSF)	r	0.18	–0.14	–0.40	0.50	–0.03	–0.07	–0.09	0.18	–0.34
	P	0.58	0.65	0.20	0.10	0.92	0.82	0.78	0.58	0.28
Albumin (CSF)	r	0.36	0.08	–0.36	0.50	0.29	0.01	0.04	0.28	–0.39
	P	0.28	0.81	0.28	0.12	0.38	0.98	0.90	0.41	0.24
IgG (CSF)	r	0.01	–0.22	–0.36	0.39	–0.26	–0.21	–0.10	0.03	–0.39
	P	0.99	0.51	0.28	0.24	0.44	0.54	0.76	0.93	0.24
C3	r	–0.02	0.02	0.08	–0.11	0.11	0.24	–0.25	–0.09	–0.14
	P	0.93	0.92	0.70	0.62	0.61	0.26	0.25	0.66	0.52
C4	r	–0.18	–0.04	0.20	0.02	–0.11	0.10	–0.25	–0.10	–0.16
	P	0.41	0.84	0.34	0.93	0.60	0.64	0.24	0.64	0.46
Globulin	r	–0.08	–0.21	–0.39	0.02	–0.10	–0.14	–0.23	0.03	–0.04
	P	0.70	0.29	0.05	0.92	0.64	0.49	0.25	0.87	0.86
Albumin	r	0.09	0.26	0.22	–0.20	0.29	0.38	0.06	–0.16	–0.02
	P	0.67	0.20	0.27	0.32	0.15	0.05	0.77	0.45	0.91
IgG	r	0.01	–0.33	–0.41	0.11	–0.18	–0.10	–0.17	–0.14	–0.12
	P	0.96	0.11	0.04	0.60	0.38	0.64	0.40	0.50	0.57
IgA	r	–0.13	0.08	–0.14	0.0008	–0.03	–0.08	–0.20	0.26	0.07
	P	0.52	0.71	0.51	1.00	0.90	0.69	0.34	0.20	0.75
IgM	r	–0.18	0.05	0.01	–0.29	–0.07	0.10	–0.15	0.17	0.18
	P	0.40	0.82	0.98	0.17	0.74	0.63	0.47	0.42	0.39
IgE	r	–0.18	–0.40	–0.26	0.24	–0.03	–0.02	–0.04	0.04	0.03
	P	0.40	0.05	0.21	0.24	0.87	0.91	0.86	0.85	0.88
24 h proteinuria	r	0.22	–0.19	–0.37	–0.02	–0.28	–0.30	0.10	0.11	0.40
	P	0.31	0.37	0.08	0.93	0.19	0.17	0.65	0.61	0.06
Cr	r	0.03	0.17	0.19	–0.05	–0.15	–0.26	0.12	0.09	0.23
	P	0.90	0.41	0.36	0.79	0.47	0.20	0.55	0.68	0.26
BUN	r	0.09	–0.30	–0.08	–0.04	–0.18	–0.11	–0.07	–0.11	–0.09
	P	0.68	0.13	0.71	0.85	0.37	0.58	0.72	0.58	0.66
UA	r	0.06	0.09	0.15	–0.11	–0.20	–0.21	0.12	0.12	0.46
	P	0.79	0.65	0.47	0.60	0.33	0.29	0.54	0.57	0.02
GFR	r	–0.03	–0.18	–0.02	–0.08	0.19	0.15	–0.30	–0.14	–0.45
	P	0.90	0.37	0.94	0.71	0.35	0.46	0.14	0.48	0.02
CRP	r	–0.32	–0.20	–0.12	–0.06	–0.35	–0.004	–0.16	–0.13	–0.18
	P	0.11	0.32	0.55	0.78	0.08	0.99	0.43	0.52	0.38
ESR	r	–0.24	–0.32	–0.20	–0.17	–0.30	–0.27	–0.28	0.10	0.09
	P	0.26	0.12	0.35	0.41	0.15	0.19	0.18	0.63	0.66
WBC	r	–0.09	0.29	–0.05	–0.14	–0.11	0.07	0.11	–0.21	–0.09
	P	0.68	0.15	0.83	0.49	0.61	0.74	0.60	0.31	0.67
HB	r	0.03	0.21	0.35	–0.15	0.22	0.38	–0.19	–0.04	–0.02
	P	0.89	0.31	0.08	0.46	0.28	0.05	0.35	0.85	0.91
PLT	r	–0.10	0.25	–0.16	–0.02	–0.08	0.04	–0.05	0.07	0.31
	P	0.61	0.23	0.43	0.92	0.69	0.86	0.80	0.73	0.12
Urinary RBC	r	0.72	0.26	–0.32	0.24	0.30	–0.04	0.17	0.35	–0.10
	P	<0.0001	0.19	0.11	0.23	0.14	0.85	0.41	0.08	0.63
D-Dmier	r	0.17	0.08	0.0008	–0.16	–0.09	0.05	–0.23	–0.19	–0.14
	P	0.45	0.73	1.00	0.47	0.69	0.83	0.30	0.39	0.53
CD4+ T cells	r	–0.60	0.18	0.28	–0.24	–0.14	0.08	–0.51	0.05	–0.03
	P	0.12	0.67	0.50	0.56	0.74	0.84	0.20	0.90	0.94
CD8+ T cells	r	–0.55	0.08	0.27	0.29	0.06	0.36	0.03	–0.03	–0.16
	P	0.15	0.84	0.52	0.48	0.89	0.38	0.95	0.94	0.71
NK cells	r	0.11	0.36	0.35	0.05	0.41	0.58	–0.05	–0.26	0.002
	P	0.79	0.38	0.40	0.90	0.31	0.13	0.91	0.53	1.00
B cells	r	–0.44	–0.31	–0.58	0.04	–0.83	–0.00008	–0.45	–0.04	–0.01
	P	0.79	0.38	0.40	0.90	0.31	0.13	0.91	0.53	1.00
PAH	r	–0.58	–0.41	0.60	–0.41	–0.55	–0.08	–0.62	–0.52	–0.46
	P	0.04	0.16	0.03	0.17	0.05	0.80	0.02	0.07	0.12
CFH	r	–0.10	0.08	0.31	–0.32	–0.03	–0.50	0.43	0.21	0.03
	P	0.24	0.45	0.14	0.21	0.13	0.12	0.08	0.13	0.90
P2RY14	r	–0.34	0.23	0.32	0.34	–0.34	–0.38	0.42	–0.06	–0.32
	P	0.24	0.34	0.35	0.12	0.09	0.34	0.23	0.92	0.13
VNN1	r	0.34	0.24	0.03	0.08	0.23	0.53	–0.23	–0.024	0.03
	P	0.22	0.25	0.48	0.83	0.32	0.39	0.07	0.98	0.83
IDO1	r	–0.61	–0.09	–0.28	0.08	–0.43	0.09	0.32	–0.05	–0.54
	P	0.02	0.19	0.32	0.92	0.09	0.84	0.34	0.67	0.09
BCL2A1	r	0.45	0.38	0.42	0.37	–0.33	0.93	–0.92	–0.43	–0.42
	P	0.03	0.05	0.32	0.22	0.06	0.10	0.35	0.93	0.23
KCNJ15	r	–0.34	0.54	0.23	–0.84	–0.03	0.23	–0.33	0.45	–0.32
	P	0.50	0.14	0.06	0.32	0.94	0.24	0.09	0.34	0.32

The r and P values of nonparametric analysis are listed. SLEDAI, SLE disease activity index; yrs, years; NPSLE, neuropsychiatric systemic lupus erythematosus; WBC (CSF), white blood cells in cerebrospinal fluid; Protein (CSF), protein in cerebrospinal fluid; Albumin (CSF), albumin in cerebrospinal fluid; IgG (CSF), immunoglobulin G in cerebrospinal fluid; C3, complement 3; C4, complement 4; IgG, immunoglobulin G; IgA, immunoglobulin A; IgM, immunoglobulin M; IgE, immunoglobulin E; 24 h proteinuria, 24 hour proteinuria; Cr, creatinine; BUN, urea nitrogen; UA, uric acid; GFR, glomerular filtration rate; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; WBC, white blood cells; HB, hemoglobin; PLT, platelet; Urinary RBC, urinary red blood cells; NK cells, natural killer cell; PAH, pulmonary hypertension; CFH, complement factor H; P2RY14, purinergic receptor P2Y14; VNN1, vanin 1; IDO1, Indoleamine 2,3-dioxygenase 1; BCL2A1, BCL2 related protein A1; KCNJ15, Potassium voltage-gated channel subfamily J member 15.